NEW HAVEN, Conn., Sept. 6, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will present a corporate overview at two upcoming investor conferences:
- Morgan Stanley Global Healthcare Conference on Monday, September 9, 2013 at 3:50 p.m. ET at Grand Hyatt New York, in New York, NY; and
- Baird's 2013 Health Care Conference on Tuesday, September 10, 2013 at 1:45 p.m. ET at The New York Palace Hotel in New York, NY.
CONTACT: Company Contact: Glenn Schulman Achillion Pharmaceuticals, Inc. Tel. (203) 752-5510 firstname.lastname@example.org Investors: Mary Kay Fenton Achillion Pharmaceuticals, Inc. Tel. (203) 624-7000 email@example.com